Therefore, increasing the expression of CUL3 while using SHH activators could not only play an anti-apoptotic and anti-oxidative role in the SHH pathway, but also reduce the level of excessive proliferation and migration of VSMCs, thereby hindering the development of hypertension. This evidence concerns the gene SHH and hypertensive disorder.